Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,496.30
Market cap: ₹1,03,108 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.4×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Employee Stock Options 6 Annual General Meeting 5 Other Announcement 4 Management Change 4 Earnings Call 4 Financial Results 3 Debt & Borrowing 3 Results Update 2 Credit Rating 2 Board Meeting Date 2 Share Pledge 1 Partnership 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Jun 2026 17:38 IST BSE

Acquisition

Mankind Pharma Acquisition Worth ₹0.75 Cr

Mankind Pharma's subsidiary acquired the remaining 10% stake in Upakarma Ayurveda for ₹0.75 Crore. This transaction makes Upakarma a wholly-owned step-down subsidiary to improve operational efficiencies.

Value: ₹0.75 Cr

Read the filing ↗